Japan’s Regenerative Medicine Market:
Expedited Approval System Creates New Opportunities for Canadian Cell Therapy Companies and Researchers
JETRO and the Centre for Commercialization of Regenerative Medicine (CCRM) are hosting a seminar on Japan's Regenerative Medicine Market on January 29th, 2016 at the Hilton Toronto. The event is supported by the International Society for Cellular Therapy and the Ontario Institute for Regenerative Medicine.
In 2014, Japan introduced an expedited approval system for regenerative medicine products as well as other reforms related to the supply of stem cells.
Foreign companies and researchers are now looking at Japan as a potential location for clinical trials. There are also new business opportunities emerging for foreign companies as Japan develops its regenerative medicine related infrastructure.
Speakers at this event will explain about the new expedited approval system in Japan and give examples of on-going collaborations between Canada and Japan in the field of regenerative medicine.
Program Link: https://www.jetro.go.jp/ext_images/canada/pdf/rmseminar012916.pdf
This event is free but pre-registration by January 22 is required.
To register or for more information, please contact JETRO Toronto:
Tel: 416-861-0000 x206;